"Overall lung cancer" trang 1 - tải miễn phí từ tailieunhanh
Genetic polymorphism rs3760396 of the chemokine (C-C motif) ligand 2 gene (CCL2) associated with the susceptibility of lung cancer in a pathological subtype-specific manner in Han-ancestry Chinese: A case control study

Genetic polymorphism rs3760396 of the chemokine (C-C motif) ligand 2 gene (CCL2) associated with the susceptibility of lung cancer in a pathological subtype-specific manner in Han-ancestry Chinese: A case control study
7    71    1
The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: A retrospective study

The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: A retrospective study
10    34    1
NKX2–1 expression as a prognostic marker in early-stage non-small-cell lung cancer

NKX2–1 expression as a prognostic marker in early-stage non-small-cell lung cancer
9    47    1
Comparative analysis of overall survival in non-small cell lung cancer patients with and without different organ metastases

Comparative analysis of overall survival in non-small cell lung cancer patients with and without different organ metastases
6    11    1
Clinicopathological variables influencing overall survival, recurrence and postrecurrence survival in resected stage I nonsmall-cell lung cancer

Clinicopathological variables influencing overall survival, recurrence and postrecurrence survival in resected stage I nonsmall-cell lung cancer
10    74    0
Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies

Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies
10    75    1
Development of a well-defined tool to predict the overall survival in lung cancer patients: An African based cohort

Development of a well-defined tool to predict the overall survival in lung cancer patients: An African based cohort
11    2    1
Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective

Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective
10    54    1
Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines

Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines
9    47    1
Molecular identification of an immunityand Ferroptosis-related gene signature in non-small cell lung Cancer

Molecular identification of an immunityand Ferroptosis-related gene signature in non-small cell lung Cancer
9    56    1
Inflammation‑scores as prognostic markers of overall survival in lung cancer: A register‑based study of 6,210 Danish lung cancer patients

Inflammation‑scores as prognostic markers of overall survival in lung cancer: A register‑based study of 6,210 Danish lung cancer patients
10    62    3
Long-term results of postoperative unsuspected small cell lung cancer on real-world data

Long-term results of postoperative unsuspected small cell lung cancer on real-world data
10    2    1
The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: A systematic review and meta-analysis

The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: A systematic review and meta-analysis
9    64    1
Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: Results of a prospective single-center study

Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: Results of a prospective single-center study
9    71    1
Lung cancer incidence differences in migrant men in Belgium, 2004–2013: Histology-specific analyses

Lung cancer incidence differences in migrant men in Belgium, 2004–2013: Histology-specific analyses
15    18    1
Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer

Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer
6    46    1
Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: A SEER cancer registry analysis

Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: A SEER cancer registry analysis
6    94    0
Improved uptake and survival with systemic treatments for metastatic non-small cell lung cancer: Younger versus older adults

Improved uptake and survival with systemic treatments for metastatic non-small cell lung cancer: Younger versus older adults
11    4    1
Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients

Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients
6    6    1
A systematic analysis of immune genes and overall survival in cancer patients

A systematic analysis of immune genes and overall survival in cancer patients
9    70    0